A detailed history of Bay Colony Advisory Group, Inc D transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 5,340 shares of EW stock, worth $402,529. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,340
Previous 5,343 0.06%
Holding current value
$402,529
Previous $493,000 28.6%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$59.7 - $93.78 $179 - $281
-3 Reduced 0.06%
5,340 $352,000
Q2 2024

Jul 24, 2024

BUY
$84.3 - $94.31 $252 - $282
3 Added 0.06%
5,343 $493,000
Q4 2023

Jan 29, 2024

SELL
$61.71 - $77.76 $59,673 - $75,193
-967 Reduced 15.33%
5,340 $407,000
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $436,948 - $588,947
6,307 New
6,307 $436,000
Q2 2022

Aug 08, 2022

BUY
$86.5 - $128.27 $201,977 - $299,510
2,335 New
2,335 $235,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.